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Introduction
Alternative activation of microglia/macrophages (M2a) is purported to be protective after spinal cord injury (SCI) participating in intrinsic survival, growth, and repair processes (David and Kroner, 2011) . Nonetheless, the M2a phenotype is poorly understood in vivo and recent studies indicate that it may be impaired with normal aging (Fenn et al., 2012; Lee et al., 2013) . Impaired M2a microglial regulation may explain why older individuals (60ϩ years) have reduced functional recovery and increased mortality after a traumatic injury to the brain or spinal cord National SCI Statistical Center, 2013) . Indeed, in rodent models of traumatic brain injury, a worse functional outcome in the aged corresponded with reduced IL-4 signaling (Kumar et al., 2013) and increased CNS inflammation (Sandhir et al., 2008) . Few studies, however, have investigated a mechanism for increased age-associated morbidity and mortality after SCI. This is a significant problem because incidence of SCI in aged individuals has increased fivefold in the last 30 years and currently comprises 15% of SCI cases each year (Fassett et al., 2007) . Thus, a better understanding of how different microglia/macrophage phenotypes affect SCI recovery in the aged is required.
Understanding of distinct microglia/macrophage phenotype has expanded within the last decade. Unfortunately, M1, M2a, M2b, and M2c phenotyping has primarily been done in vitro and whether or not these distinct phenotypes develop in vivo and what functions they perform are not well defined (Mosser and Edwards, 2008) . In the context of SCI, the IL-4-driven M2a phenotype has received the most attention because it may support a level of endogenous repair (David and Kroner, 2011) . For example, in models of nerve and spinal cord injury, increased expression of the M2a marker arginase was associated with prolonged axonal protection (Barrette et al., 2010) and improved neuronal growth and survival (Cao et al., 2005) . Moreover, media from IL-4-treated macrophages enhanced neurite growth in vitro . Thus, an inability to respond to IL-4/IL-13 and induce an M2a phenotype after SCI may impede functional recovery in the aged.
Therefore, the aims of this study were twofold: (1) test the hypothesis that impaired IL-4R␣ induction and M2a regulation of microglia in the aged CNS results in an attenuated microglial response and worse functional outcome after SCI and (2) better characterize the M2a phenotype in vivo in the context of SCI and inflammation. We show novel data that aged mice had reduced functional recovery after SCI associated with failed induction of IL-4R␣ and reduced M2a responses in microglia (reduced arginase), but also reduced inflammatory cytokine (IL-1␤) and chemokine (CCL2) expression necessary to recruit IL-4R␣ ϩ monocytes/macrophages to the injured spinal cord. Moreover, evidence from immune-based studies shows that induction of IL-4R␣ on microglia was required for IL-4-dependent arginase expression in vivo and axon outgrowth ex vivo. Last, inflammatory-activated microglia reprogrammed with IL-4 in vivo increased expression of IL-1␤ mRNA associated with heightened CCL2 in the brain and enhanced recruitment of CCR2 
Materials and Methods
Mice. Adult BALB/c mice were obtained from a breeding colony kept in barrier-reared conditions in a specific pathogen-free facility at The Ohio State University. A breeding colony was established for adult IL-4R␣-deficient (IL-4R␣ KO ) mice on a BALB/c background (BALB/cIl4ra tm1Sz /J; #003514). Breeding pairs were purchased from Jackson Laboratories. Adult C57BL/6 mice were purchased from Charles River Breeding Laboratories, adult C57BL/6-Tg (CAG-EGFP) 131/leysopJ mice (#006567) were purchased from The Jackson Laboratory, and aged BALB/c mice (18 -22 months) were purchased from the National Institute on Aging specific pathogen-free colony (maintained at Charles River Laboratories). Mice were individually housed in polypropylene cages and maintained at 25°C under a 12 h light/dark cycle with ad libitum access to water and rodent chow. All procedures were in accordance with the National Institute of Health Guidelines for the Care and Use of Laboratory Animals and were approved by The Ohio State University Institutional Laboratory Animal Care and Use Committee.
SCI. SCI was performed as previously described (Jakeman et al., 2000; Donnelly et al., 2011) . In brief, mice were deeply anesthetized using ketamine and xylazine (100 and 10 mg/kg BW i.p., respectively) and received a laminectomy at vertebral level T9 or a laminectomy followed by a spinal cord contusion using the Infinite Horizons device (75 kdyn; Precision Systems and Instrumentation). Mice were returned to a slidewarmed cage (35Ϫ37°C) with three to four mice per cage and administered 2 ml sterile saline, and 100 l Gentocin (5 ml/kg) subcutaneously. Mice were maintained on the slide-warmed cage overnight. Mice receiving a spinal cord contusion underwent bladder expression twice daily for the duration of the experiment.
Motor recovery. Basso Mouse Scale (BMS) scoring was completed as previously described (Basso et al., 2006) . In brief, mice were acclimated to a plastic-bottomed open field (100 cm diameter, 21 cm wall height) every other day for 1 week before injury. Because BALB/c mice freeze in an open field under bright light, dim light was used for all BMS testing. After injury mice were placed individually in the open field 1, 3, 5, 7, 14, 21, and 28 d post injury (dpi). During testing mice were scored for 4 min by two observers blinded to experimental treatment. Mice were rated by on a scale of 0 -9. Testing was completed during the light phase at the same time each day.
Purification of enriched microglia from brain. Enriched microglia were isolated from brain as previously described (Henry et al., 2009; Fenn et al., 2012) . In brief, the brain was homogenized through a 70 m cell strainer and centrifuged to collect a cell pellet. Cells were then suspended in a discontinuous Percoll density gradient (70%/50%/35%/0%) and centrifuged. Microglia and peripherally derived CD11b ϩ cells were collected at the 70%/50% Percoll interphase (Henry et al., 2009; Wohleb et al., 2012) . In these studies, Percoll-isolated cells were primarily microglia. For example, Percoll-isolated cells from control mice (Saline-Veh, Saline-IL-4) were ϳ78% CD11b ϩ /CD45 lo microglia and ϳ3% CD11b ϩ / CD45 hi peripherally derived macrophages and granulocytes. Following lipopolysaccharides (LPS; LPS-Veh, LPS-IL-4) the percentage shifted to ϳ75% microglia and ϳ9% peripherally derived macrophages and granulocytes. Based on these percentages, Percoll-isolated cells from the brain are referred to as "enriched microglia."
Purification of enriched CD11b ϩ cells from spinal cord. Enriched CD11b ϩ cells were isolated from the spinal cord as previously described (Donnelly et al., 2011) . In brief, the entire spinal cord was homogenized through a 70 m cell strainer and centrifuged to collect a cell pellet. Cells were then suspended in a modified discontinuous Percoll density gradient (70%/35%/0%) and centrifuged. Microglia and peripherally derived CD11b ϩ cells were collected at the 70%/35% Percoll interphase. Because of this modified gradient, a larger proportion of isolated cells was not of a CD11b ϩ lineage and likely consisted of other brain glia including astrocytes (Norden et al., 2014) . Nonetheless, in these studies Percollisolated cells from laminectomy mice were ϳ58% CD11b ϩ /CD45 lo microglia, ϳ2% CD11b ϩ /GR1 lo/neg macrophages, and ϳ1.5% CD11b ϩ / GR1 hi granulocytes. Following SCI the percentage shifted to ϳ43% microglia, ϳ6% macrophages, and ϳ6% granulocytes. Because of the lower proportion of microglia isolated from the spinal cord and increase in peripherally derived cells, Percoll-isolated cells from the spinal cord are referred to as "enriched CD11b ϩ cells." Intracerebroventricular cannulation and injections. Intracerebroventricular cannulation was performed as previously described (Huang et al., 2008) . In brief, mice were deeply anesthetized using ketamine and xylazine (100 and 10 mg/kg BW i.p., respectively). A 26 gauge stainless steel guide cannula was placed in the lateral cerebral ventricle using the following stereotaxic coordinates from bregma: Lateral 1.2 mm; A-P 0.5 mm; and a depth of Ϫ2 mm from the dura mater. Two anchoring cranial screws were inserted adjacent to the cannula and the cannula was secured with cranioplastic cement. A dummy cannula was inserted in the guide cannula to prevent occlusion and infection. Mice were injected subcutaneously with Buprenex (111 g/kg BW) after surgery and again 24 h later. Mice were provided a minimum of 7 d to recover before treatment.
After at least 7 d post intracerebroventricular cannulation, mice were given an intraperitoneal injection of saline or LPS (0.33 mg/kg-BALB/c; 0.5 mg/kg-C57BL/6). One hour later mice received a 2 l volume intracerebroventricular injection of vehicle (0.1% BSA) or IL-4 (25 ng/l) at a rate of 1 l/min. Twenty-four hours after LPS injection mice were killed or perfused and brains were collected for flow cytometric, RNA, or immunohistochemical analyses.
DRG neuronal cultures with microglia. For the DRGs, cervical, thoracic, and lumbar DRG neurons were isolated from the spinal cord as described previously (Gensel et al., 2009) . In brief, DRGs were dissected from an adult BALB/c mouse spinal cord and plated at a density of 800 cells/well in a 24-well plate and maintained in fresh media (Neurobasal A with 2% B27 supplement (Invitrogen), 1% GlutaMAX, and 1% penicillin/streptomycin) at 37°C/5% CO 2 for 3 d before treatment. After 3 d, a separate subset of adult BALB/c mice was injected with saline or LPS intraperitoneally. After 4 h microglia were isolated by Percoll gradient separation and added at a density of ϳ1 ϫ 10 5 cells/well to 0.4 m transwell inserts situated directly above DRG neurons. Microglia/DRG cocultures were then treated with vehicle (0.1% BSA) or IL-4 (20 ng/ml) for 24 h. GFP ϩ bone marrow-chimera. Bone marrow (BM)-chimeras were established using chemical ablation with busulfan and reconstitution of the BM with donor cells obtained from C57BL/6-Tg (CAG-EGFP) mice as previously described (Wohleb et al., 2013) . In brief, recipient C57BL/6 male mice (6 weeks old) were injected intraperitoneally once daily for 2 consecutive days with busulfan in a 1:1 solution of DMSO and deionized H 2 O (30 mg/kg/100 l). Donor C57BL/6-Tg (CAG-EGFP) BM-derived cells were isolated from the femur, passed through a 70 m cell strainer, and the total number of cells was determined with a BD Coulter Particle Count and Size Analyzer (Beckman Coulter). Donor BMderived cells (1 ϫ 10 6 ) were transferred to recipient mice by tail vein injection (100 l) 48 h after the second dose of busulfan. Mice were left undisturbed for 4 weeks to allow for engraftment. Engraftment was verified by determining the percentage of GFP ϩ cells in the BM and the blood. Mice that had Ͻ30% BM engraftment were excluded from the study.
RNA isolation and RT-PCR. RNA was isolated from a 1 mm coronal brain section or two, 1 mm spinal cord sections immediately adjacent to the injury epicenter using the TriReagent protocol (Sigma) and subjected to the DNA-free RNA clean up procedure (Ambion) according to manufacturer instructions. RNA was isolated from Percoll-enriched microglia or CD11b ϩ cells using the PrepEase kit (Affymetrix) according to manufacturer's instructions. Real-time (RT)-PCR was performed using the Applied Biosystems TaqMan Assayson-Demand Gene Expression protocol as previously described (Wohleb et al., 2011 (Wohleb et al., , 2012 . In brief, experimental cDNA was amplified by RT-PCR where a target cDNA (e.g., IL-1␤, arginase I, CCL2) and a reference cDNA (GAPDH) were amplified simultaneously using an oligonucleotide probe with a 5Ј fluorescent reporter dye (6-FAM). Fluorescence was determined on an ABI PRISM 7300 sequence detection system (Applied Biosystems). Data were analyzed using the comparative threshold cycle method and results are expressed as fold difference from GAPDH.
Flow cytometry. Cells were assayed for surface antigens by flow cytometry as previously described (Henry et al., 2009; Fenn et al., 2013) . In brief, Percoll-enriched microglia or CD11b ϩ cells were incubated with rat anti-mouse CD14-FITC, CD11b-PE, CD45-PerCP-Cy5.5, and CCR2-APC antibodies (eBioscience). For the GFP chimera experiments, cells were fluorescent for GFP (FITC ϩ PE channels) and incubated with CD45-PerCP-Cy5.5 and CD11b-APC antibodies. Expression of these surface receptors was determined using a BD FACSCalibur four-color cytometer. Ten thousand events characterized as microglia/macrophages were recorded. Microglia and macrophages were identified by CD11b ϩ / CD45 lo and CD11b ϩ /CD45 hi expression, respectively (Wohleb et al., 2011) . For each antibody, gating was determined based on appropriate negative isotype-stained controls. Flow data were analyzed using FlowJo software (Tree Star).
Immunohistochemical staining. Mice were killed by CO 2 and transcardially perfused with 0.1 M PBS followed by 4% formaldehyde. Tissues were cryoprotected with 30% sucrose for 72 h following postfixation. For all tissues three representative images from each sample were taken for analysis. Fluorescent images were taken with a Zeiss 510 Meta confocal microscope and analyzed using MetaMorph Analysis software (Molecular Devices). DAB/eriochrome cyanine (EC) images were taken with a Carl Zeiss Axioplan 2 Imaging microscope and analyzed using ImageJ NIH software.
Spinal cord. spinal cords were rapidly frozen in OCT compound. Serial coronal sections (10 m) were cut using a Microm HM550 cryostat (Mikron Instruments) and collected every 100 m throughout a 5 mm segment with the lesion epicenter at the middle. Sections were stained with antibodies against arginase I (1:200; Santa Cruz Biotechnology) and Brain. Brains were frozen in dry-ice cooled isopentane. Coronal sections (10 m) were cut using a Microm HM550 cryostat and collected every 20 m throughout the intracerebroventricular injection site. Sections were stained with antibodies against arginase I (1:200; Santa Cruz Biotechnology) and Iba-1 (1:1000; Wako Chemicals) for fluorescent staining. Images were taken from the region adjacent to the intracerebroventricular injection site and up to 100 m distal to the injection site for imaging of the choroid plexus.
DRG cultures. DRG neurons were fixed with 2% formaldehyde for 20 min and stained with ␤-tubulin-III (1:2000; Sigma). Images were taken every 1500 m across a coverslip with a Carl Zeiss Axioplan 2 Imaging microscope and analyzed using MetaMorph Analysis software (Molecular Devices). Only images that contained a DRG neuronal cell body were analyzed. Neurite growth was determined by the proportional area of ␤-tubulin-III labeling. DRG cell bodies were excluded in the analysis of ␤-tubulin-III proportional area.
Statistical analysis. Data were subjected to the Shapiro-Wilk test using Statistical Analysis Systems (SAS) statistical software. To determine significant main effects and interactions between main factors, data were analyzed using one-way (i.e., Pretreatment and Treatment), two-way (i.e., Pretreatment ϫ Treatment), or three-way (i.e. Pretreatment ϫ Treatment ϫ Time) ANOVA using the general linear model procedures of SAS. When appropriate, differences between treatment means were evaluated by an F-protected t test using the least-significant difference procedure of SAS. In addition, data showing the percentage of mice that 
Results
Age-related impairment in the induction of IL-4R␣ surface expression on microglia after SCI We previously reported that peripheral challenge with LPS, a potent activator of the innate immune system, markedly increased surface expression of IL-4R␣ on microglia of adult, but not aged mice (Fenn et al., 2012) . Impaired induction of IL-4R␣ on microglia from aged mice corresponded with reduced sensitivity to ex vivo IL-4 stimulation (Fenn et al., 2012) . To test if these age-associated deficits in M2a-mediated regulation would persist in vivo after an SCI, adult (3-4 months) and aged (18 -19 months) mice were subjected to a moderate (75 kdyn) midthoracic (T9) laminectomy or spinal cord contusion injury (SCI). IL-4R␣ protein expression was determined on spinal cord microglia (CD11b ϩ /CD45 lo ) at 1 dpi or 3 dpi ( Fig. 1 A, B ). Adult and aged microglia were analyzed using separate age-matched isotype controls because of higher autofluorescence in aged microglia as a result of lipofuscin accumulation (Fig. 1B; Fenn et al., 2012) . Fig.  1 , A-C, shows that a moderate SCI increased microglial surface expression of IL-4R␣ in the spinal cord of adult mice at 1 dpi ( p Ͻ 0.006) and 3 dpi ( p ϭ 0.08), but was not increased on microglia of aged mice at either time point (Age ϫ SCI: F (2,33) ϭ 10.39, p Ͻ 0.008).Thus, SCIinduced IL-4R␣ expression on microglia was impaired in aged mice. Next, two 1 mm sections of the spinal cord adjacent to the injury epicenter were collected for mRNA expression of IL-4 and IL-13. IL-4 mRNA was significantly increased 3 dpi independent of age ( p Ͻ 0.02; Fig. 1D ). In contrast, IL-13 mRNA was reduced after SCI, but only in adult mice (Age ϫ SCI: F (2,23) ϭ 6.11, p Ͻ 0.01). Although aged mice had lower IL-13 levels at baseline ( p Ͻ 0.04), IL-13 mRNA was maintained after SCI in aged mice and was significantly higher at 3 dpi compared with adult mice ( p Ͻ 0.05). Therefore, microglial IL-4R␣ induction was impaired with age, but IL-4 and IL-13 levels were maintained or increased in aged mice after SCI.
Diminished presence of IL-4R␣
؉ myeloid cells in the spinal cord of aged mice after injury A hallmark of SCI is the active recruitment of peripheral myeloid cells (i.e., granulocytes, monocytes) to the injury site Sroga et al., 2003; Shechter et al., 2009 Shechter et al., , 2013 . As these cells may also express IL-4R␣, IL-4R␣ expression was determined on granulocytes (CD11b ϩ /CD45 hi /GR-1 hi ) and monocytes/macrophages (CD11b ϩ /CD45 hi / GR-1 lo ) in the spinal cord at 1 and 3 dpi. The flow cytometric gating strategy is illustrated in Fig. 2A . Both monocytes and macrophages are described here as macrophages. Fig. 2B shows that the relative number of GR1 hi granulocytes was increased 1 dpi ( p Ͻ 0.0001) and 3 dpi ( p Ͻ 0.0001) independent of age. Moreover, GR-1 hi granulocytes did not express high levels of IL-4R␣ (Fig. 2C) . Indeed, Ͼ95% of the IL-4R␣ ϩ , peripherally derived cells were GR-1 lo macrophages (data not shown). Of the IL-4R␣ ϩ myeloid cells after SCI, ϳ70 -75% were microglia and ϳ25-30% were macrophages (Fig. 2C ). Fig. 2C shows that by combining the contribution of granulocytes, macrophages, and microglia the total relative number of IL-4R␣ ϩ cells was robustly increased in the spinal cord of adult mice at 1 dpi ( p Ͻ 0.01) and 3 dpi ( p ϭ 0.09), whereas the IL-4R␣ ϩ cell number remained unchanged in aged mice at either time point (Age ϫ SCI: F (2,33) ϭ 4.83, p Ͻ 0.02; Fig. 2C ).
Next, we investigated if the proportion of macrophages recruited or maintained in the injured spinal cord differed with age. At 1 dpi the total relative number of macrophages (both IL-4R␣ and IL-4R␣ ϩ ) in the spinal cord of aged mice was increased compared with adult mice ( p Ͻ 0.04; Fig. 2D ). Despite this increase in macrophage number, the proportion of IL-4R␣ ϩ macrophages was reduced in aged mice from ϳ35% at baseline down to Ͻ15% by 3 dpi ( p Ͻ 0.01; Fig. 2E ) and the proportion of IL-4R␣ ϩ macrophages was increased in adult mice from ϳ18% at baseline, to Ͼ40% at 1 and 3 dpi ( p Ͻ 0.0002). Collectively, these data indicate that there is impaired induction of IL-4R␣ on microglia of aged mice associated with an altered distribution of IL-4R␣ ϩ macrophages after SCI.
Enhanced IL-1␤ and CCL2 mRNA expression in adult mice after SCI Because macrophage recruitment after SCI was affected by age, mRNA expression of two key mediators of myeloid cell recruitment (IL-1␤ and CCL2) were measured proximal to the injury epicenter. In these experiments, adult WT, aged WT, and adult IL-4R␣ KO mice were used. All mice for these experiments were on a BALB/c background. Fig. 3A shows that IL-1␤ mRNA was significantly increased at 1 dpi ( p Ͻ 0.0001), but was higher in the spinal cords of adult mice compared with aged mice (Age ϫ SCI: F (1,23) ϭ 14.95, p Ͻ 0.001). Similarly, adult mice had exaggerated expression of CCL2 mRNA 1 dpi compared with aged mice (Age ϫ SCI: F (1,23) ϭ 6.03, p Ͻ 0.03; Fig. 3B ). By 3 dpi IL-1␤ and CCL2 mRNA expression levels were not different between age groups. A similar profile of IL-1␤ and CCL2 mRNA expression was detected in adult IL-4R␣ KO mice compared with WT controls. Indeed, IL-1␤ and CCL2 mRNA expression were reduced in IL-4R␣ KO mice compared with WT mice at 1 and 3 dpi, respectively (IL-1␤: p ϭ 0.09; CCL2: p Ͻ 0.0001; Fig. 3C,D) . Functional IL-4R␣ signaling in adult WT mice corresponded with increased expression of IL-1␤ and CCL2 and enhanced recruitment of IL-4R␣ ϩ macrophages to the injured spinal cord.
Arginase protein expression was reduced in the injured spinal cord of aged mice
Here we show that IL-4R␣ induction on microglia was impaired in aged mice after SCI. Our previous studies indicate that a lack of IL-4R␣ induction results in reduced IL-4-mediated arginase (Fenn et al., 2012) . Therefore, arginase, a key marker of M2a microglia/macrophages, was determined in adult WT, aged WT, and adult IL-4R␣ KO BALB/c mice 7 dpi. This time point (7 dpi) represents the peak of arginase expression after SCI in adult mice . Fig. 4 , A and B, shows representative labeling ofarginaseandTomLinadultWT,agedWT,andadultIL-4R␣ KO mice after SCI. Similar to our previous work (Sroga et al., 2003; , a dense accumulation of TomL ϩ microglia/macrophages was evident in the injury epicenter. Moreover, arginase protein was increased after SCI and colocalized specifically with TomL ϩ microglia/macrophages (Fig. 4 B, C). Consistent with impaired IL-4R␣ upregulation on microglia/ macrophages of aged mice, arginase expression was significantly reduced in the epicenter of Aged-SCI mice ( p Ͻ 0.009) compared with Adult-SCI mice (tendency for SCI ϫ Age: F (1,15) ϭ 3.40, p ϭ 0.09; Fig. 4D) . A similar pattern of reduced arginase expression was evident in adult IL-4R␣ KO mice compared with WT mice ( p Ͻ 0.02; Fig. 4D ). These data indicate that IL-4R␣-dependent arginase induction was significantly reduced in myeloid cells of aged mice 7 dpi.
Aged mice had impaired functional recovery and extended lesion length after SCI Reduced arginase expression in the injured spinal cord of aged mice may point to deficiencies in endogenous repair and worse functional recovery after SCI. To test this, functional recovery was assessed over a 28 d period after SCI using the BMS (Basso et al., 2006; Fig. 5A ). Age alone did not influence the BMS score for uninjured mice as all Lam controls had similar scores over the 28 d testing period. Following SCI, however, both adult and aged BALB/c mice exhibited significant motor impairments that improved over the 28 d time period (SCI ϫ Time: F (6,153) ϭ 19.57, p Ͻ 0.0001). Nonetheless, spontaneous recovery was significantly reduced in aged mice compared with adult mice at 1, 3, 5, 7, 21, and 28 dpi (Age ϫ SCI: F (1,153) ϭ 12.96, p Ͻ 0.0001).
A significant functional milestone in recovery from SCI is the ability to achieve frequent or consistent bilateral weightsupported stepping. Mice that achieved a BMS score of 5 have achieved this recovery milestone. Fig. 5B shows that ϳ75% of the Adult-SCI mice achieved a BMS score of 5 by 28 dpi, but none of the Aged-SCI mice reached this level of recovery ( p Ͻ 0.0001). Aged mice averaged a BMS score of 3 associated with hindlimb plantar placement, but without stepping.
After the completion of locomotor testing at 28 dpi, the percentage of tissue sparing and total lesion length was determined (Donnelly et al., 2011) . Although tissue sparing at the lesion epicenter was reduced by 10% in aged spinal cords, this was not significantly different from adults (Fig. 5C ). Lesion length, however, was 38% longer in Aged-SCI mice compared with Adult-SCI mice ( p ϭ 0.06; Fig. 5 D, E) . Indeed, 1.2 mm rostral and caudal of the epicenter Aged-SCI tissue still showed evidence of a lesion, whereas the lesion was not present in Adult-SCI mice at this distance (Fig. 5D) . Thus, aged mice had reduced functional recovery and an extended lesion size compared with adult mice following SCI.
To evaluate the extent to which reduced IL-4R␣ expression contributed to functional recovery deficits in aged BALB/c mice, functional recovery was tested in WT and IL-4R␣ KO BALB/c mice 28 d after SCI. Similar to aged mice, adult IL-4R␣ KO -SCI mice showed worse functional recovery at 28 dpi compared with adult WT-SCI mice. For example, similar to other immune receptor KOs (e.g., TLR2 KO ; , IL-4R␣ KO mice did not significantly differ in BMS score compared with WT mice (data not shown) but had a BMS subscore that was ϳ73% lower than WT controls ( p ϭ 0.07; Fig. 5F ). Moreover, 50% of WT mice achieved a BMS score of 5, whereas only 33% of IL-4R␣ KO mice achieved this functional milestone (Fig. 5G) . Also, 25% of WT mice achieved a BMS score of 6 (frequent/consistent stepping with some coordination) but 0% of IL-4R␣ KO mice reached this score (Fig. 5H ) . Collectively, these studies indicate that reduced IL-4R␣ expression in IL-4R␣
KO and aged mice contributes to impaired functional recovery after SCI.
IL-4R␣ induction on activated microglia was required for IL-4-dependent arginase expression
Our data indicate that aged mice had reduced functional recovery after SCI associated with impaired microglial induction of IL-4R␣. An age-related deficit in IL-4R␣ upregulation corresponded with attenuated arginase expression, reduced IL-1␤ and CCL2 expression, and reduced presence of IL-4R␣ ϩ macrophages in the injured spinal cord. Nonetheless, it is difficult to understand the significance of enhanced or impaired IL-4/IL-4R␣ signaling in microglia after SCI because the onset and nature of the inflammatory stimulus is not known, arginase induction is partially IL-4-indpendent (Fig. 4C) , and various crosssignaling mechanisms likely control the magnitude and effect of inflammation. Therefore, we moved to an immune-based model in adult mice in which the inflammatory stimulus (LPS) and delivery of IL-4 could be better controlled and M2a profile examined.
Adult BALB/c mice were surgically implanted with an indwelling cannula in the lateral ventricle. After 7 d, mice were given an intraperitoneal injection of saline or LPS to promote an inflammatory response in the CNS. After 1 h, mice were then given an intracerebroventricular injection of vehicle or IL-4. Fig. 6A shows that 24 h after LPS, IL-4R␣ expression was upregulated on microglia in the spinal cord ( p Ͻ 0.05) and the brain ( p Ͻ 0.05) to a similar extent. Because cannulas for central IL-4 infusion can be better established in the brain, we investigated IL-4/ IL-4R␣-induced M2a responses in brainresident microglia. Fig. 6B shows that intracerebroventricular administration of IL-4 increased mRNA expression of arginase by ϳ10-fold, and this induction was augmented over 160-fold in mice that were pretreated with LPS (LPS ϫ IL-4: F (1,32) ϭ 4.4, p Ͻ 0.05). Peripheral injection of LPS alone, however, did not increase arginase mRNA expression.
To confirm these mRNA results and to determine the extent to which the induction of arginase was microglia specific, arginase protein was measured in brainresident microglia (Iba-1 ϩ ) proximal to the intracerebroventricular injection site (Fig. 6C) . Representative images of Iba-1 (Fig.6Di, green) and arginase (Fig.6Dii,  red) labeling are shown. Arginase protein was not present in the brain of the control mice (Saline-Vehicle) or mice injected with just LPS (LPS-Vehicle; Fig. 6 D, F ) . Although a low level of arginase was induced by IL-4 (Saline-IL-4) consistent with the mRNA data (Fig. 6B ), this was not significantly different from control mice. Arginase protein, however, was markedly increased in the brain of mice that received both peripheral LPS and intracerebroventricular IL-4 (LPS ϫ IL-4: F (1,14) ϭ 23.72, p Ͻ 0.0005; Fig. 6 D, F ) . Moreover, this robust induction of arginase was detected specifically in Iba-1 ϩ microglia (Fig. 6Div,E) . These data indicate that inflammatory-induced IL-4R␣ upregulation on microglia is required for these cells to respond to IL-4 and increase arginase protein expression.
After SCI, aged mice had deficits in microglial IL-4R␣ induction with corresponding impairments in arginase protein expression. Therefore, the same immune-based protocol as above was also performed in a subset of adult (3 months) and aged (20 months) BALB/c mice to assess arginase protein expression. Representative images of the Adult-LPS-IL-4 group and Aged-LPS-IL-4 group are shown (Fig. 6G) . Increased lipofuscin accumulation in the brain with age often results in increased background labeling for immunohistochemistry or flow cytometry (Sierra et al., 2007; Fenn et al., 2012) . Indeed, arginase labeling was sevenfold higher in Aged-Saline-Vehicle controls compared with adult-Saline-Vehicle controls (data not shown). Thus, to assess the level of exaggerated arginase expression in the Aged-LPS-IL-4 group, arginase protein expression was compared with age-matched Saline-IL-4 controls. Fig. 6H shows that IL-4-mediated reprogramming of active microglia to an arginase ϩ phenotype was attenuated by 79% in the brain of aged mice compared with adults. These data indicate that reprogramming of activated microglia by IL-4 was impaired with age. Thus, a robust induction of arginase in vivo required (1) an inflammatory/activating signal and (2) responsiveness to an M2a reprogramming signal. . Aged mice had impaired functional recovery and extended lesion length after SCI. Adult female (3-4 months) and aged female (18 -22 months) BALB/c mice were subjected to a T9 laminectomy (Lam) or SCI. Functional recovery was assessed by BMS scoring over a 28 d period after SCI. Spinal cords were collected 28 dpi. A, BMS scores for 1, 3, 5, 7, 14, 21, and 28 dpi for Lam controls (n ϭ 4) and SCI mice (n ϭ 10 -13). B, Percentage of adult and aged SCI mice that achieved an average BMS score of Ն5 at 28 dpi. C, Quantification of epicenter tissue sparing using neurofilament/EC staining (n ϭ 4). D, Representative images of neurofilament/EC staining in injured spinal cord of adult and aged mice 1.2 mm rostral and caudal of the epicenter. Dark staining denotes intact axons and myelin sheathing. E, Lesion length from adult and aged mice (n ϭ 4). In a separate study, adult male WT (2-4 months) and adult male IL-4R␣ KO (3-4 months) BALB/c mice were subjected to a T9 Lam or SCI. F, BMS subscore for WT and IL-4R␣ KO mice at 28 dpi (n ϭ 8). G, Percentage of WT and IL-4R␣ KO SCI mice that achieved an average BMS score of 5 at 28 dpi (n ϭ 8). H, Percentage of WT and IL-4R␣ KO SCI mice that achieved an average BMS score of 6 at 28 dpi (n ϭ 8). Error bars and data points represent the mean Ϯ SEM. Means with *p Ͻ 0.0001 are significantly different from Adult-Lam controls. Means with # p Ͻ 0.03 are significantly different from Adult-SCI or WT-SCI groups. Means with ϩ p ϭ 0.07 tend to be different from Adult-SCI or WT-SCI groups.
IL-4-mediated reprogramming of activated microglia supported neurite outgrowth
Previous studies show that M2a microglia/macrophages (arginase ϩ ) promote axon growth in vitro and enhance remyelination in vivo (Kigerl et al., 2009 ). Whether or not a similar repair potential is elicited in microglia primed by an inflammatory stimulus has not been tested. Therefore, axon growth was determined in adult DRG neurons cocultured with inflammatoryactivated microglia, with or without IL-4. Adult BALB/c mice were injected intraperitoneally with saline or LPS. After 4 h microglia were isolated and cultured ex vivo in transwell inserts placed directly over DRG neurons isolated from adult BALB/c mice 3 d prior. Cocultures were then treated with either vehicle or IL-4 and neurite outgrowth was measured 24 h later. Fig. 7A shows representative images from the four different experimental groups. There was a significant interaction between microglia activation and IL-4 stimulation (LPS ϫ IL-4, F (1, 20) ϭ 4.77, p Ͻ 0.05) on DRG axon outgrowth (e.g., increased proportional area of ␤-tubulin-III staining). For instance, ␤-tubulin-III proportional area was reduced when neurons were cocultured with inactive microglia treated with IL-4 (Sal-IL-4; p Ͻ 0.03). Moreover, ␤-tubulin-III proportional area was unaffected by coculture with active microglia alone (LPS-Vehicle). ␤-tubulin-III proportional area was highest, however, when DRG neurons were cocultured with active microglia reprogrammed with IL-4 (LPS-IL-4; p ϭ 0.1; Fig. 7B ). These data are interpreted to indicate that IL-4-mediated reprogramming of activated microglia supported neurite outgrowth and complexity.
IL-4-mediated reprogramming of activated microglia augmented mRNA expression of IL-1␤ and CCL2
Differential distribution of macrophages in the aged spinal cord after SCI was associated with impaired IL-4R␣ induction on microglia, reduced arginase expression, and reduced mRNA expression of IL-1␤ and CCL2. The LPS model confirmed that IL-4-mediated reprogramming of inflammatory microglia induced a robust arginase response similar to that observed after Adult-SCI. Therefore, IL-1␤ and CCL2 mRNA were measured in a coronal brain section 24 h after LPS and IL-4 treatments in adult BALB/c mice. As expected, microglial mRNA expression of IL-1␤ was increased 24 h after LPS compared with saline controls ( p ϭ 0.08; Fig. 8A ). Consistent with the SCI studies, IL-1␤ mRNA expression was further enhanced by intracerebroventricular IL-4 treatment (LPS ϫ IL-4, F (1, 44) inflammatory-associated factors IL-1␤ and CCL2 compared with treatment with LPS alone.
IL-4-mediated reprogramming of activated microglia increased the trafficking of CCR2
؉ macrophages to the brain We show increased mRNA expression of IL-1␤ and CCL2 at 1 dpi in the spinal cord of adult mice compared with aged mice (Fig. 3) and that IL-4 reprogramming of active microglia promoted the expression of IL-1␤ and CCL2 (Fig. 8) . This is important because these are two critical factors associated with recruitment of macrophages to the CNS. Indeed, increased IL-1␤ and CCL2 corresponded with increased association of IL-4R␣ ϩ macrophages with the spinal cord of adult mice (Fig. 2) . Therefore, we sought to determine the extent to which IL-4 promotes macrophage recruitment to the CNS in our immune-based studies. To assess macrophage trafficking C57BL/6 mice were used (Wohleb et al., 2013). First, IL-4R␣ induction on enriched microglia of WT C57BL/6 mice after LPS was confirmed, and this induction was unaffected by intracerebroventricular IL-4 (data not shown). Second, the relative proportion of microglia and brain-associated macrophages was determined after intraperitoneal LPS and intracerebroventricular IL-4 injections. Representative bivariate dot plots of CD11b and CD45 labeling on Percoll-isolated brain microglia (CD11b (Fig. 9A) . Consistent with the SCI studies, Fig. 9B shows that the highest percentage of brain-associated macrophages was measured in mice with activated microglia reprogrammed by intracerebroventricular IL-4 (LPS-IL-4, p Ͻ 0.04). Next, the phenotype of recruited macrophages was investigated. IL-4R␣ expression was assessed on macrophages following a saline or LPS injection alone. In these experiments 65% of IL-4R␣ ϩ cells were also CCR2 ϩ (data not shown). Of the CCR2 ϩ macrophages, only 5% expressed IL-4R␣ protein under basal conditions (Saline) and this proportion increased to Ͼ20% after LPS injection (Fig. 9C) . Thus, IL-4R␣ is expressed primarily on CCR2 ϩ macrophages and CCR2 ϩ macrophages increase their expression of IL-4R␣ following an LPS challenge.
Next we investigated the recruitment of CCR2 ϩ macrophages after intracerebroventricular IL-4 treatment. Fig. 9D shows that post treatment with intracerebroventricular IL-4 after LPS enhanced trafficking of CCR2 ϩ macrophages to the brain ( p Ͻ 0.03). The expression of CCR2 on a per cell basis (i.e., CCR2 MFI) was also enhanced following LPS-IL-4 treatments compared with LPS-Veh controls (Fig. 9E, p ϭ 0.1) . Analysis of both CCR2 and CX 3 CR1 expression on brain-associated macrophages indicated that CCR2 ϩ cells were selectively retained or recruited after LPS and IL-4 (77 Ϯ 3%) compared with LPS alone (66 Ϯ 3%, p Ͻ 0.05; Fig. 9E ). The breakdown of the expression of CCR2 and CX 3 CR1 is shown in the LPS-Veh and LPS-IL-4 groups in Fig. 9E . Compared with LPS alone (LPS-Veh), there was a relative increase in the percentage of CCR2 ϩ /CX 3 CR1 lo (67% from 60%) and CCR2 ϩ /CX 3 CR1 neg macrophages (10% from 3%), and relative reduction in the percentage of CCR2 neg /CX 3 CR1 hi (19% from 27%) and CCR2 neg /CX 3 CR1 neg (4% from 7%) macrophages in the LPS-IL-4 group. To confirm that these macrophages were BM derived and to determine their neuroanatomical distribution, GFP BMchimera mice on a C57BL/6 background were established (Wohleb et al., 2013) . Flow cytometric analysis confirmed that the increased population of CD11b ϩ / CD45
hi cells 24 h after LPS was peripherally derived (Fig. 9F ) . Next, the neuroanatomical distribution and M2a phenotype (arginase ϩ ) was examined at the intracerebroventricular injection site and nearby choroid plexus. Fig. 10A shows representative images of GFP ϩ / Iba-1 ϩ /arginase ϩ cells in the injection site 24 h after LPS in LPS-Vehicle and LPS-IL-4 treatment groups. Histological analysis confirmed the flow cytometric studies and revealed that trafficking of BM-derived cells to the brain was significantly increased in LPS-IL-4-treated mice compared with all other groups ( p Ͻ 0.03; Fig. 10B ). Moreover, these peripherally derived GFP ϩ cells, similar to resident microglia, were capable of expressing arginase in response to IL-4. Indeed, in mice injected with both intraperitoneal LPS and intracerebroventricular IL-4, ϳ25% of all GFP ϩ cells were also arginase ϩ (Fig.  10A) . Of the arginase ϩ cells, ϳ45% were microglia (Iba-1 ϩ ), ϳ40% were peripherally derived cells that had trafficked into the brain parenchyma (GFP ϩ /Iba-1 ϩ ), and ϳ15% were peripherally derived cells in the perivascular spaces (GFP ϩ ; Fig.  10C ).Together, IL-4-IL-4R␣-dependent alternative activation of microglia was associated with increased recruitment of BM-derived myeloid cells to the CNS, which in turn, were directed to an arginase ϩ phenotype.
Discussion
There is significant interest in understanding activation profiles of microglia and macrophages in aging, disease, and CNS injury. Our previous work indicates that IL-4R␣ was markedly enhanced on microglia of adult, but not aged mice after a peripheral LPS challenge (Fenn et al., 2012) . Moreover, LPS-activated microglia from adult mice were more responsive to IL-4 ex vivo than aged mice (Fenn et al., 2012) . The primary aim of this study was to determine whether impaired IL-4/M2a microglial regulation in the aged CNS resulted in immune and functional deficits after SCI. The secondary aim was to better understand the role of M2a microglia/macrophages in vivo in the context of inflammation and aging. We show original data that IL-4R␣ was enhanced after SCI on microglia of adult, but not aged, mice. IL-4R␣ upregulation corresponded with increased IL-1␤ and CCL2 mRNA expression, enhanced association of IL-4R␣ ϩ macrophages with the injured spinal cord, increased arginase expression, and improved functional recovery. Immune-based studies revealed that IL-4-dependent arginase required inflammatory-induced IL-4R␣ expression. Moreover, treatment with IL-4 in the inflammatory CNS directly augmented the expression of inflammatory mediators (IL-1␤, CCL2) and enhanced CCR2
ϩ /IL-4R␣ ϩ macrophage recruitment. Thus, IL-4 drove a unique M2a microglial phenotype (arginase ϩ /IL-1␤ ϩ ), which supported both intrinsic repair and the recruitment of peripheral myeloid cells. Moreover, this phenotype was reduced in aged mice corresponding with limited recovery after SCI.
One important aspect of this study was that aged mice had worse functional recovery after SCI compared with adults. For example, ϳ75% of adults had frequent or consistent stepping with no coordination (BMS score ϭ 5) by 28 dpi compared with 0% of aged mice that achieved this score. Consistent with a worse BMS score, lesion length was longer in aged mice at 28 dpi. These data are consistent with previous studies showing increased pathology and demyelination (Siegenthaler et al., 2008) and worse functional recovery (Gwak et al., 2004) in middle-aged (12 months) rats after a spinal cord contusion or hemisection. Here we extend these findings in mice of advanced age (18 -19 months) and provide evidence of impaired reprogramming of microglia. These data are clinically relevant because no basic models of SCI in advanced ages had been established and a mechanism for worse recovery had not been proposed Fassett et al., 2007; National SCI Statistical Center, 2013) . Impaired functional recovery at 28 dpi was also recapitulated in adult IL-4R␣ KO mice. Together, our data using both models indicate that IL-4/IL-4R␣ dysfunction is a key contributing factor to poorer functional recovery after SCI.
A potential mechanism for increased morbidity after SCI in the aged mice is reduced responsiveness to IL-4 by microglia/ macrophages. We focused on IL-4 rather than IL-13 because IL-4 was increased in both adult and aged mice after SCI, whereas IL-13 was reduced acutely after SCI in adults. Although the increase in IL-4 mRNA was undetectable until 3 dpi, other studies have detected IL-4 protein from microglia at 1 dpi (Guerrero et al., 2012) corresponding to the time point of IL-4R␣ upregulation. The source of IL-4 was not determined here because of a lack of cell specificity in our RNA analyses of the spinal cord, but other studies suggest that IL-4 may derive from spinal cordresident microglia (Guerrero et al., 2012) , or infiltrating myeloperoxidase-positive neutrophils (Lee et al., 2010) . Whatever the source, IL-4 mRNA induction in adult and aged mice was the same. Therefore, reduced IL-4R␣, rather than reduced IL-4, was responsible for the less arginase ϩ myeloid cells in aged mice. These findings are consistent with a previous study showing that equivalent levels of IL-4/IL-13 resulted in attenuated upregulation of IL-4/IL-13-response genes in aged mice compared with adults (Lee et al., 2013) . The link between IL-4R␣ impairments and reduced arginase, IL-1␤, and CCL2 expression in aged mice after SCI was further confirmed using adult IL-4R␣ KO mice. Notably, although arginase expression was reduced in the spinal cords of IL-4R␣ KO and aged mice, it was not ablated. The role of this IL-4R␣-independent arginase expression remains to be elucidated, but here we demonstrate that reduced IL-4/IL-4R␣-dependent arginase corresponded with an impaired immune response and reduced functional recovery.
Another important aspect of this study was our M2a profile analysis in vivo in the context of active inflammation. IL-4-driven M2a responses in microglia/macrophages are primarily reported using in vitro culture systems with either pretreatment or cotreatment of IL-4 followed by an inflammatory stimulus. In those studies, IL-4 increased arginase expression and reduced inflammatory mediators including IL-1␤ and TNF-␣ (Kitamura et al., 2000; Butovsky et al., 2006; Lyons et al., 2007) . In vivo, however, IL-4 concentrations are low/undetectable at baseline and are increased after the establishment of an inflammatory response to injury. Thus we aimed to better model these conditions with an immune-based approach in which microglia were activated using a peripheral LPS injection and then IL-4 was provided centrally 1 h later. In both the SCI and LPS-intracerebroventricular IL-4 experiments, IL-4/IL-4R␣-mediated responses increased arginase, but also augmented the expression of IL-1␤, and CCL2 in microglia or brain/spinal cord. Thus, this arginase ϩ /IL-1␤ ϩ microglia phenotype may better represent an "alternative activation" state in vivo. Although this phenotype may be perceived as "inflammatory," it is still beneficial for restricting pathology. For example, intact IL-4/IL-4R␣ signaling in Adult-SCI mice corresponded to reduced tissue lesion length and better functional recovery than aged mice. Moreover, the arginase ϩ /IL-1␤ ϩ microglial phenotype induced by LPS-IL-4 treatment promoted DRG neurite growth/complexity ex vivo. In contrast, IL-4 alone failed to increase arginase protein and DRG neurite growth was reduced. Although our previous studies report increased DRG neurite growth with IL-4 alone (Gensel et al., 2009; , those studies were performed using BM-derived macrophages and did not involve coculture. The results presented here are consistent with a previous study in which IL-4 treatment 2 h after LPS reduced nitric oxide production and motor neuron death beyond that of pretreatment with IL-4 (Zhao et al., 2006) .
Increased neurite growth in the presence of inflammation is consistent with recent studies examining microglial activation in neurite development and axonal dieback. For example, DRG neurons cultured with conditioned media from BM-derived macrophages activated with zymosan (TLR-2/dectin-1 agonist) had increased axonal growth over baseline (Gensel et al., 2009) . Moreover, pharmacological induction of inflammatory mediators (IL-1␤, CCL2, and iNOS) protected against axonal dieback in a model of laser-induced SCI (IL-1␤, CCL2, and iNOS; Stirling et al., 2014) . Mice with attenuated inflammatory responses (i.e., TLR2 KO mice, minocycline treatment), however, had worse functional outcome after a contusive SCI Stirling et al., 2014) and impaired axon regeneration after sciatic nerve injury (Kwon et al., 2013) . Thus, an intact inflammatory response by microglia may be protective in the context of SCI.
Recruiting a specific macrophage population after SCI is another way in which IL-4 reprogramming of active microglia may be beneficial. Indeed, functional IL-4/IL-4R␣ signaling in Adult-SCI mice corresponded to increased association of IL-4R␣ ϩ monocytes with the spinal cord, whereas the injured spinal cord of aged mice was dominated by IL-4R␣ Ϫ macrophages. These results were mirrored in the immune-based studies wherein LPS-IL-4 treatment increased IL-1␤ and CCL2 expression corresponding with increased recruitment of CCR2 lo monocytes are characterized as iNOS lo and associated with less pathology after SCI (Donnelly et al., 2011) . Moreover, depletion of CCL2 is associated with reduced recovery after SCI (Shechter et al., 2009 ). CCL2 may be enhanced after IL-4 treatment as a result of increased polyamine levels. Arginase is the rate-limiting enzyme for production of polyamines, a necessary factor for CCL2 induction and macrophage recruitment to the brain (Puntambekar et al., 2011) . Therefore, IL-4 signaling after SCI may be required for the recruitment or maintenance of a macrophage population that participates in repair. In further support of this idea, administration of an IL-4-expressing adenoviral vector into the CNS drives expression of chemokines to recruit other cells involved in immune regulation (i.e., regulatory T-cells) in a mouse model of multiple sclerosis (Butti et al., 2008) .
In support of IL-4-driven recruitment of reparative macrophages, our experiments show that peripherally derived macrophages also developed an arginase ϩ phenotype after LPS-IL-4 treatment. This arginase ϩ phenotype is important because peripherally derived IL-4R␣ ϩ /arginase ϩ myeloid cells can function as myeloid derived suppressor cells (MDSCs; Bronte et al., 2003; Pesce et al., 2009; Kohanbash et al., 2013) . Elimination of MDSC recruitment after SCI reduced arginase, IL-10, and IL-1␤ expression and caused worse functional recovery (Saiwai et al., 2013) . It is unclear if peripherally derived IL-4R␣ ϩ /arginase ϩ myeloid cells exhibited here suppress T-cell responses consistent with MDSC function. Nonetheless, it is clear that IL-4 reprogramming of active microglia increases the association of CCR2 ϩ /arginase ϩ peripheral myeloid cells with the CNS. In summary, inflammatory-induced IL-4R␣ on microglia promoted increased sensitivity to IL-4 resulting in elevated arginase, IL-1␤, and CCL2 expression and the recruitment of peripherally derived CCR2 ϩ /IL-4R␣ ϩ cells to the CNS to benefit recovery after SCI. These data provide an innovative cellular perspective on IL-4 signaling and the pathophysiology of agerelated deficits after CNS trauma.
